Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03064932 · ClinicalTrials.gov registry record · NA

Effect of a Spice Blend on Cardiovascular Risk Factors and Diet Satisfaction

A NA study of Cardiovascular Disease and Inflammation, sponsored by Penn State University.

Completed
Registry status
NA
Development phase
71
Enrollment target
1
Study location

NCT03064932 is a NA study of Cardiovascular Disease and Inflammation that has completed, run by Penn State University. The registered enrollment target is 71 participants, below the 2,713-participant average among 136 other Cardiovascular Disease trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03064932, a NA study of Cardiovascular Disease and Inflammation, has completed, sponsored by Penn State University.

COMPLETED
Registry status
NA
Development phase
71 participants
Enrollment target
1
Study location

Study Summary

This study is a randomized 3-period crossover, controlled feeding study designed to evaluate the effects of the most commonly consumed spices in the U.S. on CVD risk factors, inflammation \& immune function, and diet satisfaction in participants at risk for CVD.

Interventions

  • OTHER Controlled feeding diet

Study Locations (1)

Pennsylvania

  • Penn State University - University Park

Trial Details

FieldValue
Enrollment Target 71 participants
Start Date 2017-01-25
Est. Completion 2020-02-26
Phase NA

Sponsor

Penn State University

219 total trials

What the Registry Record Tells You About NCT03064932

The ClinicalTrials.gov registry entry for NCT03064932 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 71 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,713-participant average among 136 other Cardiovascular Disease trials with a reported enrollment target (97% lower). The listed sponsor is Penn State University, which has 219 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Cardiovascular Disease appearing as the primary indexed condition, and to 1 intervention - of which Controlled feeding diet is the first listed.

NCT03064932 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT03064932 about?

NCT03064932 is a clinical study titled "Effect of a Spice Blend on Cardiovascular Risk Factors and Diet Satisfaction". This study is a randomized 3-period crossover, controlled feeding study designed to evaluate the effects of the most commonly consumed spices in the U.S. on CVD risk factors, inflammation \& immune function, and diet satisfaction in participants at risk for CVD.

What is the current status of trial NCT03064932?

This trial is currently completed. It is a NA study. The enrollment target is 71 participants. The study started on 2017-01-25. Estimated completion is 2020-02-26.

What conditions does trial NCT03064932 study?

This clinical trial studies the following conditions: Cardiovascular Disease, Inflammation.

What interventions are being tested in trial NCT03064932?

The interventions under investigation include: Controlled feeding diet (OTHER).

Who is sponsoring clinical trial NCT03064932?

This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03064932 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiovascular Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.